Quality By Design: A Review
Abstract
Quality by Design is the most recent quality-related trend in pharmaceutical manufacturing (QbD). This paper discusses Pharmaceutical Quality by Design (QbD) as a way to guarantee high-quality pharmaceuticals. Details about Quality by Design are given in addition to a list of its components. The quality parameters and attributes of each unit operation are unique. Pharmaceutical products can benefit from Quality by Design and the steps that can be taken to implement it. High-quality pharmaceuticals and their manufacturing processes form the core of pharmaceutical R&D. It is impossible to verify the quality of a product because this document includes a breakdown of the product's quality profile and the most important aspects of Quality by Design. Comparing the quality of various products can be done in two ways: through Quality by Design and end-product testing (QbD). Quality by Design is based on the ICH Guidelines. ICH guidelines govern the development of pharmaceuticals and the implementation of quality assurance systems. Pharmaceutical development and production can benefit from Quality by Design (QbD).
Keywords: Concept & background of QbD, Traditional vs QbD Approach, Key elements, PAT, Challenges, Current & Future perspective.
Keywords:
Concept & background of QbD, Traditional vs QbD Approach, Key elements, PAT, Challenges, Current & Future perspectiveDOI
https://doi.org/10.22270/jddt.v12i2-S.5451References
Nadpara NP, Thumar R V, Kalola VN, Patel PB. Review Article Quality By Design (Qbd): A Complete Review. 2012; 17(2):20–8.
Woodcock J, The concept of pharmaceutical quality American Pharmaceutical Review, 2004; 7(6):10–5,
Q9: Quality Risk Management. ICH Harmonized Tripartite Guidelines. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2006.
Q10: Pharmaceutical Quality System, ICH Tripartite Guidelines. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2007.
Lionberger RA, Lee LS, Lee L, Raw A,Yu LX. Quality by design: Concepts for ANDAs. The AAPS Journal 2008; 10:268–276. https://doi.org/10.1208/s12248-008-9026-7
Q8 (R1): Pharmaceutical Development, Revision 1, ICH Harmonized Tripartite Guidelines, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2007.
Jain S. Quality by design (QbD): a comprehensive understanding of implementation and challenges in pharmaceuticals development. Int J Pharm Pharm Sci. 2013; 6:29-35.
Drakulich, A. Critical challenges to implementing QbD: A Q&A with FDA. Pharm. Technol. 2009; 33:90–94.
Pokharana M, Vaishnav R, Goyal A, Shrivastava A, Stability testing guidelines of pharmaceutical products, Journal of Drug Delivery and Therapeutics 2018; 8(2):69-175. https://doi.org/10.22270/jddt.v8i2.1564
Roy S, Quality by design: A holistic concept of building quality in pharmaceuticals. International Journal of Pharmaceutical and Biomedical Research. 2012; 3(2):100-108.
Gawade A, Chemate S and Kuchekar A. Pharmaceutical Quality by Design: A New Approach in Product Development. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. 2013; 2:5-11.
Lawrence X. Yu (2006) Director of science. “Implementation of Quality by Design”, Question based review.
Lourenco V, Herdling T, Reich G, et al. Combining microwave resonance technology to multivariate data analysis as a novel PAT tool to improve process understanding in fluid bed granulation. Eur J Pharm Biopharm 2011; 78(3):513-521. https://doi.org/10.1016/j.ejpb.2011.02.008
Burggraeve A, Monteyne T, Vervaet C, et al. Process analytical tools for monitoring, understanding, and control of pharmaceutical fluidized bed granulation: A review. Eur J Pharm Biopharm 2013; 83(1):2-15. https://doi.org/10.1016/j.ejpb.2011.02.008
Delasko J.M, Cocchetto D, Burke L.B, Target product profile: Beginning drug development with the end in mind, Jan/Feb2005; Issue 1.http://www.fdli.org.
Published
Abstract Display: 2175 
PDF Downloads: 1499 PDF Downloads: 212 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.